PHILUSA Corporation has partnered with Bayer Philippines to provide world-class quality medicines at affordable prices through RHEA Generics. The partnership aims to transform healthcare accessibility in the Philippines. The signing event occurred on February 5, 2024, at Bayer Philippines Head Office, attended by PHILUSA Corporation President Neogin Evangelista, Bayer Philippines Managing Director Angel Michaelo Evangelista, and Mercury Drug Corporation Vice President Corazon Lim.
This partnership marks the 12th collaboration for RHEA Generics, with Bayer Philippines joining the roster of PHILUSA Corporation’s global pharmaceutical partners. Together, these industry giants aim to provide Filipino patients with an effective product for the prevention of stroke and treatment of thromboembolic events. “We’re here to help Filipino patients access affordable generic medicines while ensuring their quality, safety, and efficacy,” said Mr. Neogin Evangelista.
The Philippines, with its diverse demographic and varying lifestyle patterns, is witnessing an increase in cases of stroke. According to the Department of Health (DOH), stroke is included in the top three leading causes of death in the country, affecting both urban and rural populations. Mr. Angel Michaelo Evangelista shared that more than half a million patients are affected by this disease, and the partnership aims to redefine the standards of healthcare affordability and availability standards. “Our mission is health for all. We are committed to ensuring that stroke-prevention medicine is available through our partner, RHEA Generics. This will provide enhanced patient access to high-quality and affordable medicine.” The broad distribution reach of Mercury Drug is also instrumental in making public health within reach. Ms. Corazon Lim stated, “Our customers are assured of availability, affordability, and accessibility.”’
Launched in 2014, RHEA Generics is a uni-brand of innovative generic medicines developed in partnership with global leaders in the pharmaceutical industry, namely Pfizer, Viatris, Sanofi, GSK, Otsuka, Merck, Fresenius Kabi, OEP Philippines, Lundbeck, Boehringer Ingelheim, and AstraZeneca. Its portfolio of medicines includes treatments for hypertension, diabetes, hypercholesterolemia, respiratory infections, and chronic kidney disease, among others.
RHEA Generics are available at Mercury Drug Store branches nationwide. RHEA Generics Products is a homegrown PHILUSA Corporation brand and a generics industry pioneer with over 40 years of experience producing world-class quality and affordable healthcare products. For more information and updates, follow RHEA Generics PH’s social media pages on Facebook and rheagenericsph on Instagram.
